Acute monoblastic/monocytic leukemia, in remission is a hematological malignancy characterized by the proliferation of monoblasts or monocytic cells in the bone marrow and peripheral blood. This condition is clinically significant as it requires ongoing monitoring and management to prevent relapse. The ICD-10 Code C93.01 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track treatment outcomes and resource utilization.
ICD-10 Code C93.01 represents Acute monoblastic/monocytic leukemia, in remission, a subtype of acute myeloid leukemia. This code is used when a patient has achieved remission from the disease, indicating a reduction or absence of disease symptoms. It is essential for clinical documentation and billing to reflect the patient's current status accurately, ensuring appropriate treatment and follow-up care.
Acute monoblastic/monocytic leukemia, in remission, is caused by genetic mutations leading to the uncontrolled proliferation of monoblasts or monocytic cells. This condition can progress rapidly and requires immediate medical attention to manage symptoms and prevent complications. Continuous monitoring is essential to ensure the patient remains in remission.
ICD-10 Code C93.01 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a crucial role in both acute and chronic care settings, ensuring that healthcare providers can track the patient's progress and adjust therapies as needed.
In SOAP notes, ICD-10 Code C93.01 connects subjective patient reports and objective clinical findings to a formal diagnosis of remission. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Acute monoblastic/monocytic leukemia, in remission, requires a comprehensive approach to maintain remission and prevent complications.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C93.01 is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 85025 | Complete blood count with differential. |
| 88305 | Pathology examination of bone marrow. |
| 96413 | Chemotherapy administration, intravenous. |
| 99214 | Established patient office visit, moderate complexity. |
Common Questions About Using ICD-10 Code C93.01 for Acute monoblastic/monocytic leukemia, in remission
What does it mean for a patient to be in remission?
Being in remission means that the signs and symptoms of Acute monoblastic/monocytic leukemia have significantly decreased or are no longer detectable, indicating a positive response to treatment.
How often should patients with this diagnosis be monitored?
Patients in remission should be monitored regularly, typically every 3 months, to assess for any signs of relapse and to manage ongoing health needs.
Can Acute monoblastic/monocytic leukemia come back after remission?
Yes, there is a possibility of relapse after remission, which is why continuous monitoring and follow-up care are essential for early detection and intervention.
What are the common treatments for this condition?
Treatment may include supportive care, regular blood transfusions, and monitoring for infections, as well as potential re-initiation of chemotherapy if relapse occurs.
Clinical Notes
SOAP notes
DAP notes
AI medical notes